Afuco™ Anti-Human ACVRL1 ADCC Therapeutic Antibody (PF-03446962), ADCC Enhanced
Anti-ACVRL1 ADCC Enhanced Antibody (PF-03446962) is an ADCC enhanced antibody produced by our Afuco™ platform. PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-012CL |
| Pricing | Inquiry |
| Host | Human |
| Target | ACVRL1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |